ym 022 has been researched along with egtazic acid in 1 studies
| Studies (ym 022) | Trials (ym 022) | Recent Studies (post-2010) (ym 022) | Studies (egtazic acid) | Trials (egtazic acid) | Recent Studies (post-2010) (egtazic acid) |
|---|---|---|---|---|---|
| 65 | 1 | 8 | 10,021 | 11 | 686 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Földy, C; Lee, SY; Soltesz, I; Szabadics, J | 1 |
1 other study(ies) available for ym 022 and egtazic acid
| Article | Year |
|---|---|
Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells.
Topics: Action Potentials; Animals; Animals, Newborn; Benzodiazepines; Calcium; Chelating Agents; Cholecystokinin; Egtazic Acid; Electric Stimulation; Estrenes; Guanosine Diphosphate; Hippocampus; Hormone Antagonists; In Vitro Techniques; Neurons; Parvalbumins; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Signal Transduction; Sodium Channel Blockers; Tetrodotoxin; Thionucleotides | 2011 |